Best Penny Stocks to Trade Today

Kraig Labs joins four actively traded stocks on the 247marketnews watchlist

DENVER, Colo. (247MarketNews)— More than 120 million shares have already changed hands across NFT Limited (NYSEAMERICAN:MI), Co-Diagnostics (NASDAQ:CODX), Vivakor (NASDAQ:VIVK) and  in the morning trading scan reviewed for this report. Alongside those active names, Kraig Biocraft Laboratories (OTCQB:KBLB) brings a developing commercial spider-silk business and several potential catalysts worth following.

Source: November 10 morning scanner snapshot supplied to 247marketnews. Prices and volumes are interim readings, rounded as displayed, rather than closing totals.

Kraig Labs (OTCQB:KBLB) brings commercial spider silk and /upcoming catalysts

Kraig uses genetically engineered silkworms to produce recombinant fibers incorporating spider-silk proteins. On September 29, it announced shipment of its first commercial spider silk yarn order to a globally recognized performance sports brand for a confidential apparel pilot. The material is now in a customer’s hands, giving investors a concrete development program to follow.

The next commercial catalysts include feedback from that pilot, a possible product reveal, and additional orders.

An October 26 sample shipment to a textile innovator with experience working with aerospace manufacturers adds another development opportunity. Kraig has also begun a program for new yarn constructions and blends. Public results and customer announcements remain events to watch.

There is a date on the calendar: COO Jon Rice is scheduled to present at the International Sericultural Commission Congress in Chennai, India, November 23–27. His presentation will address the commercial impact of genetic engineering on silk markets, putting Kraig’s production model before an industry audience.

Production and research provide further reasons to follow Kraig Labs. The company reported all three rearing centers operating on staggered schedules in October, following a production increase exceeding 30%. Its November 2 update introduced an early-stage dietary-additive program aimed at improving output and fiber performance. Project Atlas has established its planned gene library in living silkworm hosts; stable breeding lines and evaluation of more than 200 potential genetic combinations are the next steps toward new fiber properties.

Editor’s opinion: “Kraig has earned a place on this watchlist. Its first commercial shipment is a historic milestone for the company. I want to see what customers build with the fiber, how production expands, and what Project Atlas produces next.”

NFT Limited (NYSE American: MI) leads the volume scan

NFT Limited (NYSE American: MI) operates an online platform for trading digital artwork and provides NFT consulting services. Its 80.93 million shares in the supplied snapshot made it the most active of these four scanner names.

The company’s October 13 announcement introduced RWAIX, a proposed system for verifying digital transactions, and released its reference software publicly. NFT Limited is targeting a limited real-world pilot in the first quarter of 2027, subject to independent security review and other conditions. Pilot progress is the business development to follow.

Co-Diagnostics (NASDAQ: CODX) has earnings scheduled for tonight

Co-Diagnostics (NASDAQ: CODX) develops molecular diagnostic technologies that detect DNA or RNA. The stock showed 20.67 million shares traded in the supplied snapshot, with a specific event ahead: third-quarter results scheduled after today’s close and a conference call at 4:30 p.m. Eastern.

Commercialization is another topic to watch on that call. Its CoSara joint venture is advancing toward an anticipated tuberculosis-test launch in India, dependent on regulatory clearance. Co-Diagnostics also plans to attend the New Tools Summit on November 16 and the Union World Conference on Lung Health November 17–20. Results, cash resources and the India launch timetable give traders concrete information to evaluate as it is released.

Vivakor (NASDAQ: VIVK) trades heavily after a debt conversion update

Vivakor (NASDAQ: VIVK) provides energy transportation, storage, reuse and remediation services. Its snapshot volume stood at 10.89 million shares.

Yesterday, November 9, Vivakor announced completion of the retirement of four convertible notes with an original combined face value of approximately $15.2 million. The final outstanding balance was converted into common shares on November 6. That removes the remaining obligations under those notes, while the share issuance is relevant to dilution. The company is also targeting first-quarter 2027 commercial operations at its Houston-area remediation center, subject to permitting and commissioning. Progress toward that start is a further catalyst.

HUHUTECH (NASDAQ: HUHU) puts semiconductor infrastructure on the screen

HUHUTECH International Group (NASDAQ: HUHU) designs and implements facility-management and industrial-automation systems for semiconductor and other industrial customers. The stock showed 8.28 million shares traded in the snapshot and was also below its previous close.

On October 21, HUHUTECH announced that a subsidiary joined a consortium bidding on a semiconductor-factory gas-delivery project expected to exceed $8 million in total value. HUHUTECH’s portion would be determined by the final award. The company also said on October 1 that it expected its first HB-800 vacuum-furnace purchase agreement before year-end. Bid results and a signed furnace agreement are identifiable developments to watch as these programs advance.

For today’s session, Co-Diagnostics has the clearest scheduled announcement. NFT Limited has the largest volume reading in the supplied scan, while Vivakor and HUHUTECH show that heavy activity can accompany falling prices. Kraig Labs’ appeal centers on the next developments in its commercial spider-silk business. The useful question for each stock is whether fresh information and sustained trading interest arrive together.

Sources

1. Kraig Labs trading history — November 5 and 6, 2026; S&P Global data via Stock Analysis

2. Kraig Labs — September 29 first commercial yarn shipment

3. Kraig Labs — October 26 yarn development program and sample shipment

4. Kraig Labs — October 19 announcement of November 23–27 ISC Congress presentation

5. Kraig Labs — October 5 three-center production update

6. Kraig Labs — November 2 dietary-additive research program

7. Kraig Labs — September 24 living Atlas Gene Library milestone

8. NFT Limited — October 13 RWAIX release and proposed pilot

9. Co-Diagnostics — November 5 notice moving earnings to November 10

10. Co-Diagnostics — November 5 tuberculosis events and India launch update

11. Vivakor — November 9 convertible-note retirement announcement

12. Vivakor — October 22 Houston remediation-center update; GlobeNewswire release reprint

13. HUHUTECH — October 21 consortium bid; company release reproduced by StockTitan

14. HUHUTECH — October 1 HB-800 commercialization update

About 247MarketNews

In today’s fast-moving markets, visibility is everything and 247MarketNews provides a powerful suite of investor relations and public relations solutions designed to elevate your company’s profile quickly and effectively. Whether you’re an established name seeking broader awareness, or a micro-cap looking to break out of obscurity, 247MarketNews delivers targeted, high-impact coverage through timely news distribution, analyst report placements, featured editorials, and multi-channel amplification across financial platforms, social media, and investor communities. Our services help cut through the noise, attract institutional interest, drive exposure, and build long-term shareholder credibility, all while maintaining full SEC compliance and transparency. For Analyst Report coverage, custom IR campaigns, press release syndication, or other tailored investor and public relations solutions, contact sales@247marketnews.com to discuss how 247MarketNews can help accelerate your company’s visibility and valuation trajectory.

PAID EDITORIAL DISCLOSURE: This is a paid editorial communication intended for informational purposes only. 247MarketNews is a third-party media provider that owns KBLB shares, which are on deposit and may be sold at the editor’s discretion, and has been compensated for providing ongoing KBLB market outreach and other services.. This press release may include technical analysis and should not be construed as financial or investment advice. Trading stocks involves risks, and readers should consult with their financial advisor before making investment decisions. For further information, please visit www.247marketnews.com or https://go.247marketnews.com/kblb-disclosure/

Important Editorial Note: 247MarketNews highlights companies approaching significant catalysts and inflection points. This report reflects information available at the time of publication.  Since developments can occur rapidly, readers should independently verify current information and review all company filings and disclosures.

CONTACT:

247MarketNews

Editor@247marketnews.com

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements that are subject to various risks and uncertainties. Such statements include statements regarding the Company’s ability to grow its business and other statements that are not historical facts, including statements which may be accompanied by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words. Actual results could differ materially from those described in these forward-looking statements due to a number of factors, including without limitation, the Company’s ability to continue as a going concern, general economic conditions, and other risk factors detailed in the Company’s filings with the SEC. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake any responsibility to update such forward-looking statements except in accordance with applicable law.